FLT3 and acute myeloid leukemia: Studies in AML cell lines show no additive proapoptotic effects, but only a limited number of cell lines were examined. However, in other experimental models of Flt3-ITD-transformed cells, VPA and mTOR inhibitors had synergistic proapoptotic effects.